Sep 22, 2026 · 6 min
Kingfisher lifts outlook as Roche advances obesity treatment
Kingfisher Soars, Roche's Shot, Ericsson's Slip
The episode contrasts stronger company guidance and drug-development momentum with the pressure facing Ericsson’s growth and margins.
- 1Kingfisher exceeded first-half earnings expectations and raised its four-year profit guidance, led by Screwfix, Poland, Spain, and e-commerce.
- 2Roche’s mid-stage obesity-treatment data showed reductions in blood sugar and weight among overweight or obese patients with type 2 diabetes.
- 3Morgan Stanley downgraded Ericsson over weakening margins, limited growth prospects, and slowing North American revenue, while preferring Nokia.
Don't miss
Roche’s experimental obesity treatment posts mid-stage results showing reduced blood sugar and weight in patients with type 2 diabetes.
The brief
Kingfisher raised its four-year guidance beyond expectations after stronger-than-expected first-half earnings, with Screwfix, Poland, Spain, and e-commerce driving growth while B&Q stayed flatter.
Roche entered the obesity-drug race with promising mid-stage results: its experimental treatment reduced blood sugar and weight in overweight or obese patients with type 2 diabetes.
The Roche update matters because it places the company alongside Novo Nordisk and Eli Lilly in a market where clinical progress can quickly reshape investor expectations.
Ericsson moved in the opposite direction after Morgan Stanley downgraded it to underweight, citing weakening margins, limited revenue growth, and slowing North American sales.
Together, the three moves show how markets reward clearer earnings momentum and credible drug data while punishing a flatter outlook for established technology businesses.
What was said on this episode
2 statements · 1 positive · 1 negative
Kingfisher’s e-commerce operations performed strongly.
“e-commerce doing very well”
Listen at 1:24
Anticipated 5G network spending failed to materialize.
“There was anticipated spending on 5G networks that failed to materialise”
Listen at 3:40
Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.
Featuring
Kingfisher
Screwfix
Bloomberg Audio StudiosListen to the full episode and explore every guest, topic, and moment on PodLume.